600422 昆药集团
2026/06 - 中期
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额(514,027)289,236808,066754,330253,895
投资活动产生之现金流量净额242,923(637,003)86,028(325,528)(234,603)
筹资活动产生之现金流量净额(178,517)(654,636)(127,990)(612,897)67,799
汇率变动对现金及现金等价物的影响(2,931)(535)9871,7412,747
现金及现金等价物净增加/(减少)(452,553)(1,002,937)767,091(182,353)89,839
期初现金及现金等价物余额1,130,9872,133,9241,366,8331,549,1871,459,348
期末现金及现金等价物余额678,4351,130,9872,133,9241,366,8331,549,187